(HealthDay)—Licensed and age-appropriate vaccines for influenza are recommended for the 2021 to 2022 season for all persons aged 6 months or older who do not have contraindications, according to research published in the ...
Aug 31, 2021
0
16
The 2021-22 influenza season is likely to be more severe than average—and hit young children particularly hard—due to waning population-level immunity from the near-lack of a flu season during last winter's COVID-19 surge, ...
Aug 31, 2021
0
35
Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking ...
Aug 30, 2021
0
44
Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal ...
Aug 30, 2021
0
2
While gut microbiota play a critical role in the induction of adaptive immune responses to influenza virus infection, the role of nasal bacteria in the induction of virus-specific adaptive immunity is less clear. New research ...
Aug 17, 2021
0
247
In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.
Aug 4, 2021
0
503
Promoting health equity in immunization rates for the new vaccines against COVID-19 during the pandemic is critical, as individuals from racial and ethnic minority groups and adults living in low-income communities are disproportionately ...
Jul 29, 2021
0
2
Authors from Brigham and Women's Hospital and Harvard Medical school say the case for mandating SARS-CoV-2 vaccination among health care workers is substantially stronger than the case for mandating influenza vaccination, ...
Jul 13, 2021
1
2
The flu vaccine may provide vital protection against COVID-19, new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, concludes.
Jul 12, 2021
0
28
US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza.
Jul 7, 2021
0
777
